Maclaughlin Eric J, Ardery Gail, Jackson Eric A, Ives Timothy J, Young Rodney B, Fike David S, Carter Barry L
Department of Pharmacy Practice, Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy, Amarillo, Texas ; Departments of Family Medicine and Internal Medicine, TTUHSC School of Medicine, Amarillo, TX.
Pharmacotherapy. 2013 Sep;33(9):902-11. doi: 10.1002/phar.1276. Epub 2013 May 3.
To categorize institutional review board (IRB) challenges and solutions encountered in a multicenter practice-based research network (PBRN) study and to assess the impact of IRB requirements on the willingness of individual principal investigators (PIs) to participate in future PBRN studies.
Descriptive analysis of IRB challenges and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) trial, a multicenter prospective cluster-randomized study conducted by the National Interdisciplinary Primary Care PBRN, and a correlational analysis from a survey of individual site PIs.
IRB barriers encountered and solutions were categorized for study sites. A survey of study-site PIs was conducted with a correlational analysis assessing the impact of various IRB requirements and the willingness of individual PIs to participate in future PBRN studies; of 31 study sites participating in the CAPTION study, 28 study-site PIs were surveyed. IRBs posed a number of challenges including bias regarding the source of the application, issues regarding study design, study instruments, access to patient records, study procedures, Spanish-only speaking subjects, role of clinic physicians, interdepartmental concerns, and updates at continuing review. Responses from the PI survey (21 of 28 PIs surveyed [75% response rate]) indicated that the willingness of an individual to serve as a PI in the future was inversely related to the perceived difficulty of obtaining initial (rS = -0.599, p=0.004) and continuing (rS = -0.464, p=0.034) IRB approval.
Significant time and resources were required to address various challenges associated with IRB approval, which had a negative impact on an individual PI's willingness to participate in future PBRN projects. A revision of current rules and regulations regarding the protection of human subjects for practice-based studies, improvement in IRB processes, and support from coordinating centers may decrease the burden associated with IRB approval and increase participation in practice-based research.
对在多中心基于实践的研究网络(PBRN)研究中遇到的机构审查委员会(IRB)挑战及解决方案进行分类,并评估IRB要求对个体主要研究者(PI)参与未来PBRN研究意愿的影响。
对药剂师与医师改善当前结局协作研究(CAPTION)试验中遇到的IRB挑战及解决方案进行描述性分析,该试验是由国家跨学科初级保健PBRN开展的一项多中心前瞻性整群随机研究,并对各研究点的PI进行调查以进行相关性分析。
对研究点遇到的IRB障碍及解决方案进行分类。对研究点的PI进行调查,并进行相关性分析,评估各种IRB要求的影响以及个体PI参与未来PBRN研究的意愿;在参与CAPTION研究的31个研究点中,对28个研究点的PI进行了调查。IRB提出了许多挑战,包括对申请来源的偏见、研究设计、研究工具、获取患者记录、研究程序、仅说西班牙语的受试者、临床医师的角色、部门间问题以及持续审查时的更新等问题。PI调查的回复(28名被调查PI中的21名[回复率75%])表明,个体未来担任PI的意愿与获得初始IRB批准(rS = -0.599,p = 0.004)和持续IRB批准(rS = -0.464,p = 0.034)的感知难度呈负相关。
应对与IRB批准相关的各种挑战需要大量时间和资源,这对个体PI参与未来PBRN项目的意愿产生了负面影响。修订当前关于基于实践研究中保护人类受试者的规章制度、改进IRB流程以及协调中心提供支持,可能会减轻与IRB批准相关的负担,并增加对基于实践研究的参与度。